One Mother Beat Blood Cancer Against the Odds. Thousands of Others Are Still Searching for Their Chance.
Cape Town 19 May 2026 - Then, in January 2024, it happened: Claire blacked out at her desk while editing videos. It was her body's final, unmistakable warning. What followed was a hospital stay, a bone marrow biopsy, and a diagnosis that would change her life forever. Claire had been diagnosed with blood cancer, specifically Myelodysplastic Syndrome (MDS), a serious bone marrow condition that, without treatment, can be fatal.
She was just 30 years old. And she was far from alone. Blood cancer remains one of the top five causes of cancer death in South Africa. Despite being potentially curable, countless patients never find their matching donor in time. Claire was determined not to become another statistic.
A Road Full of Obstacles
Claire's path to diagnosis was not straightforward. Doctors initially attributed her worsening symptoms to iron deficiency, leaving her untreated as her condition quietly progressed. By the time MDS was correctly identified, the only viable path forward was a stem cell transplant.
While awaiting a donor match, Claire endured bi-weekly injections to keep her body stable, a gruelling holding pattern as her family and medical team searched for hope. That hope came through DKMS Africa, which successfully identified a fully matched, unrelated donor for Claire.
The first transplant, using cells from that 100% unrelated matched donor, was performed with great hope. Unfortunately, it was not successful.
Claire's medical team was not deterred. Turning to family, they proceeded with a haplo-identical transplant, a "half-match" procedure using stem cells donated by Claire's brother. This second transplant was successful.
Why Every Match Still Matters
Claire's outcome is cause for deep gratitude and genuine celebration. But her journey also carries an urgent message that must not be lost in the relief of her survival.
Haplo-identical transplants, where stem cells are donated by a family member who is only a partial genetic match rather than a full one, can offer a path forward when a fully matched donor cannot be found. However, this option is not available or ideal for everyone. Not all patients have a suitable family donor, and even when they do, the procedure carries greater medical complexity and risk than a fully matched stem cell transplant.
For most patients, a 100% match from an unrelated donor remains the gold standard: the safest and most effective option. Yet only around 30% of patients find a compatible donor within their own family, meaning the remaining 70% depend entirely on a stranger's decision to join the registry. The more people who register as potential donors, the greater the chance that every patient in need will find their match.
The critical shortage of registered donors, particularly from diverse ethnic backgrounds, means that for many, the search ends without a match. Despite blood cancer being potentially curable, countless patients never find their matching donor in time.
Every name added to the registry is a potential lifeline for someone, somewhere, waiting for their match.
A Family Restored
Today, Claire is recovering. Her children have their mother. Her family, who stood beside her through diagnosis, uncertainty, and two transplants, now share in a renewed sense of hope and possibility.
Her story does not end with survival. It continues with a plea to every person who has considered registering as a stem cell donor and hasn't yet done so. "Help save others like me. We need more people to register as potential stem cell donors. Your registration could mean the difference between life and death."
About DKMS
DKMS is an international non-profit organization dedicated to the fight against blood cancer. It was founded in Germany in 1991 by Dr. Peter Harf and DKMS together with the organization’s over 1,200 employees and has since relentlessly pursued the aim of giving as many patients as possible a second chance at life. With over 13 million registered donors, DKMS has succeeded in doing this more than 115,000 times to date by providing blood stem cell donations to those in need. This accomplishment has led to DKMS becoming the global leader in the facilitation of unrelated blood stem cell transplants. The organization has offices in Germany, the US, Poland, the UK, Chile, and South Africa. The organization has offices in Germany, the US, Poland, the UK, Chile, India and South Africa.
DKMS is also heavily involved in the fields of medicine and science, with its own research unit focused on continually improving the survival and recovery rate of patients. In its high-performance laboratory, the DKMS Life Science Lab, the organization sets worldwide standards in the typing of potential blood stem cell donors.
DKMS Africa received its WMDA certification in 2025, cementing its position as South Africa’s biggest and most diverse stem cell donor registry.
